NCT02463318View on ClinicalTrials.gov

The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

September 30, 2015

Conditions
Multiple SclerosisOxidative Stress
Interventions
DRUG

Melatonin

Melatonin is used for healthy subjects and multiple sclerosis patients

OTHER

Hydrogen peroxide

Hydrogen peroxide is only used for healthy subjects

Trial Locations (1)

Unknown

Solaleh Emamgholipour, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT02463318 - The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects | Biotech Hunter | Biotech Hunter